Transgenomic, Inc. (TBIO) Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
2/9/2010 8:38:00 AM
More...
|
Transgenomic, Inc. (TBIO) Executes License Option Agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC
12/18/2009 7:30:38 AM
More...
|
Transgenomic, Inc. (TBIO) Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
12/8/2009 10:35:22 AM
More...
|
Transgenomic, Inc. (TBIO) Announces Third Quarter 2009 Earnings Release Conference Call Webcast
10/29/2009 11:09:11 AM
More...
|
Transgenomic, Inc. (TBIO) Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
10/9/2009 8:24:02 AM
More...
|
Transgenomic, Inc. (TBIO) and Power3 Medical Products (PWRM) Report Identification of Abnormal Serum Proteins in Parkinson's Disease
9/2/2009 11:32:19 AM
More...
|
Transgenomic, Inc. (TBIO) Announces Appointment of New Board Members
5/26/2009 8:30:18 AM
More...
|
Transgenomic, Inc. (TBIO) Reports First Quarter 2009 Results
5/14/2009 8:22:47 AM
More...
|
Transgenomic, Inc. (TBIO) and Power3 Medical Products (PWRM) Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
5/11/2009 10:29:53 AM
More...
|
Transgenomic, Inc. (TBIO) Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
4/7/2009 10:26:24 AM
More...
|
|